These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3219948)

  • 21. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
    Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
    Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
    Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences.
    Gall MA
    Dan Med Bull; 1997 Nov; 44(5):465-85. PubMed ID: 9408734
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF; Mora C; Muros M; García J
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight (tubular) proteinuria is not related to glycaemic control in non-insulin dependent diabetes mellitus.
    al-Kassab AS; Makeen A; Wardle EN; Quwasmah AR; Nasr MA
    Diabetes Res Clin Pract; 1994 Nov; 26(1):1-6. PubMed ID: 7875044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary glycosaminoglycans in patients with incipient diabetic nephropathy].
    Ueta I; Takamatsu K; Hashimoto K
    Nihon Jinzo Gakkai Shi; 1995 Jan; 37(1):17-23. PubMed ID: 7699949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.
    Morales E; Valero MA; León M; Hernández E; Praga M
    Am J Kidney Dis; 2003 Feb; 41(2):319-27. PubMed ID: 12552492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P; Chan SP
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implications of the detection of proteinuria and microalbuminuria in insulin and non-insulin dependent diabetes.
    Watts GF; Jasik M; Cooper ME
    Aust N Z J Med; 1995 Apr; 25(2):157-61. PubMed ID: 7605300
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
    Gilbert RE; Kim SA; Tuttle KR; Bakris GL; Toto RD; McGill JB; Haney DJ; Kelly DJ; Anderson PW
    Diabetes Care; 2007 Apr; 30(4):995-6. PubMed ID: 17229944
    [No Abstract]   [Full Text] [Related]  

  • 34. The prevalence of proteinuria detected by Albustix in a defined diabetic population.
    Gatling W; Mullee MA; Hill RD
    Diabet Med; 1988 Apr; 5(3):256-60. PubMed ID: 2967147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathological findings in the urine of diabetics].
    Fuchs T; Gutensohn G
    Munch Med Wochenschr; 1969 Sep; 111(38):1885-7. PubMed ID: 5395274
    [No Abstract]   [Full Text] [Related]  

  • 36. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications.
    Hishinuma T; Tsukamoto H; Suzuki K; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):191-6. PubMed ID: 11728171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of urine dipstick test for microalbuminuria in type 2 diabetes mellitus patients.
    Krairittichai U; Potisat S; Jongsareejit A; Sattaputh C
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S6-10. PubMed ID: 21717871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrin degradation products in the urine in diabetic nephropathy].
    Khristov V; Apostolov P; Stamenova T
    Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.